Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Schizophrenia: Cause

Description: Psychotic disorders are very serious, debilitating diseases characterized by the disintegration and disruption of adaptive behavior and a loss of contact with reality. Schizophrenia is a psychiatric illness that has been much more thoroughly researched than other disorders. It involves a decline in functioning and hallucinations, delusions, and/or disturbed thought processes with symptoms persisting at least six months. This course outlines the epidemiology and etiology of schizophrenia.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

EPIDEMIOLOGY
4. Objectives
5. Prevalence and Incidence
6. Demographics and Economic Impact
7. Progress Check

PATHOPHYSIOLOGY OVERVIEW
8. Objectives
9. Biological Risk Factors
10. Environmental Risk Factors
11. Progress Check

PATHOGENESIS
12. Objectives
13. Neurodevelopmental Hypothesis
14. Diathesis-Stress Model
15. Progress Check

CONCLUSION
16. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • List the prevalence of schizophrenia and other psychotic disorders
  • Understand the economic impact and demographics of schizophrenia
  • Understand the role of genetics in development of schizophrenia
  • Delineate the environmental risk factors for schizophrenia
  • Understand the neurodevelopmental hypothesis of schizophrenia
  • Understand the diathesis-stress model of schizophrenia

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

 

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy